KPIs & Operating Metrics(New)
Assets By SegmentBreakdown Of AssetsCardiovascular Revenue By CategoryCardiovascular Revenue By RegionCardiovascular Revenue By Region AnnualContractual ObligationsDays Inventory On Hand (Dioh)Days Sales Outstanding (Dso)Deferred RevenueEmployee StatisticsGross Margin Annual %Gross Profit AnnualIncome (Loss) Before Income Tax By RegionInterational Revenue BreakdownInterventional Cardiology BreakdownInterventional Cardiology Breakdown AnnualLong Lived Assets By GeographyMedical Devices Revenue By Geography AnnualMedsurg Revenue By CategoryMedsurg Revenue By RegionMedsurg Revenue By Region AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income By SegmentOperating Income By Segment AnnualOperating Income Margin By Segment %Operating Income Margin By Segment Annual %Opex As A % Of Total Revenue %OPEX SegregationProperties By Geography (Square Feet)Property, Plant And Equipment, Net BreakdownRevenue By Business VerticalRevenue By Business Vertical %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Rhythm And Neuro Revenue By Category
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Gross Profit (2009 - 2025)

Boston Scientific recorded annual Gross Profit of $13.9 billion in FY2025, up 20.57% year-over-year from $11.5 billion in FY2024.

Boston Scientific's Gross Profit history runs 17 years deep, the most recent figure standing at $13.9 billion for FY2025.

  • In Q1 2026, Gross Profit rose 12.59% year-over-year to $3.6 billion; the TTM figure through Mar 2026 stood at $14.3 billion (up 18.31% YoY), while the FY2025 annual figure was $13.9 billion, up 20.57% from the prior year.
  • Gross Profit came in at $13.9 billion for FY2025 at Boston Scientific, up from $11.5 billion in the prior year.
  • In the past five years, Gross Profit ranged from a high of $13.9 billion in FY2025 to a low of $8.2 billion in FY2021.
  • A 5-year average of $10.4 billion and a median of $9.9 billion in 2023 frame the typical range for Gross Profit.
  • Across the five-year window, Gross Profit increased 26.81% in 2021 and climbed 6.73% in 2022, its largest moves.
  • Boston Scientific's Gross Profit stood at $8.2 billion in 2021, then grew by 6.73% to $8.7 billion in 2022, then climbed by 13.4% to $9.9 billion in 2023, then grew by 16.11% to $11.5 billion in 2024, then grew by 20.57% to $13.9 billion in 2025.
  • According to Business Quant data, Gross Profit over the past three periods registered $13.9 billion, $11.5 billion, and $9.9 billion for FY2025, FY2024, and FY2023 respectively.